Intralesional Cidofovir for Recurrent Respiratory Papillomatosis in Children

Abstract

Intralesional injection of cidofovir seems to be of benefit in the treatment of severe respiratory papillomatosis in pediatric patients. Larger prospective studies with longer follow-up will be required before cidofovir can be considered an accepted means of managing this difficult disease.